glucose uptake (Fisher et al. 2002) . A recent study by Kjøbsted et al. (2015) reported similarD r a f t D r a f t rodent colony. Rats were housed at the University of Michigan for approximately 1 week beforeexperimentation. They were provided with rodent chow (Lab Diet; PMI Nutritional International, 126 Brentwood, MO) and water ad libitum until their food was removed at 1700h the night before the 127 terminal experiment. 128
129
Muscle dissection and incubation. On the morning of the experiment between 0800 and 1000h, 130 rats were anesthetized with an intraperitoneal injection of pentobarbital sodium (50 mg/kg wt). 131
While rats were under deep anesthesia, both epitrochlearis muscles were rapidly removed by 132 dissection, and each epitrochlearis was longitudinally transected with a scalpel into two strips of 133 similar size. Each muscle strip underwent a four-step incubation process ( 
158
Western blotting. Western blotting procedures have been described previously (Sharma et al. 159 2015; Wang et al. 2016 ). An equal amount of protein of each sample was mixed with 6X 160
Laemmli buffer, boiled for 5 min, and separated using SDS-PAGE (9% resolving gel) before 161 being transferred to polyvinyl difluoride membranes. The MemCode protein stain was used to 162 confirm equal loading (Antharavally et al. 2004; Castorena et al. 2014) . Membranes were 163 blocked in 5% bovine serum albumin (BSA) in TBST (Tris-buffered saline, pH 7.5, plus 0.1% 164 Tween-20) for 1 h at room temperature and transferred to 3% BSA-TBST with the appropriate 165 primary antibody overnight at 4°C. Membranes were washed three times for 5 min in TBST and 166 incubated with secondary antibody for 1 h at room temperature. Blots were washed three times 167 for 5 min in TBST and three times for 5 min in TBS (Tris-buffered saline, pH 7.5) and then 168 subjected to enhanced chemiluminescence (Luminata Forte Western horseradish peroxidase 169 substrate no. WBLUF0100; Millipore) to visualize protein bands. Immunoreactive proteins were 170 quantified by densitometry (FluorChemE, ProteinSimple and AlphaViewSA, San Jose, CA) . 171
Values are expressed relative to the normalized average of all of the samples on each blot. 172 D r a f t repeated measures two-way analysis of variance (ANOVA) was run separately within the NoInsulin and Insulin groups. In the initial analysis, the effects of serum only and serum+AICAR 177 obscured the effects attributable to only AICAR. Because the primary interest was in the effects 178 of AICAR-induced AMPK activation, we subsequently performed further statistical analysis 179 excluding the data from the serum only or serum+AICAR conditions. For the No serum or 180 AICAR and AICAR only preincubation conditions, a two-way ANOVA was performed (Main 181
Effect of insulin, 0 or 1.2 nM; Main Effect of AICAR, 0 or 2 mM; and insulin x AICAR interaction). 182
The Shapiro-Wilk and Brown-Forsythe tests were used to test for normality and equal variance, 183
respectively. All data passed the equal variance test. Holm-Sidak post hoc analysis was 184 performed when a main effect and/or an interaction effect was/were present. Data lacking 185 normal distribution were mathematically transformed to achieve normality prior to two-way 186 ANOVA being run. Kruskal-Wallis one-way ANOVA on ranks was used if transformation failed to 187 normalize data, and pairwise multiple comparison procedure was performed by the Tukey Test. 188
Results

190
[
H]3-MG Uptake 191
The initial statistical analysis that included all four pre-incubation conditions revealed 192 significant main effects of serum (p<0.05) and AICAR (p<0.001), and an interaction effect 193 (p<0.01) on glucose uptake in muscles incubated without insulin (Figure 2A ). Post hoc analysis 194 revealed that glucose uptake for serum+AICAR > serum alone (p<0.001) and for serum+AICAR 195 > AICAR alone (p<0.001). For muscles incubated with insulin, there was a significant main 196 effect of AICAR (p<0.001). Post hoc analysis revealed that glucose uptake for AICAR > No 197 AICAR or serum group (p<0.05) and serum+AICAR > serum alone (p<0.01).
198
For the secondary analysis that excluded serum conditions, there were significant main 199 effects of insulin (p<0.01) and AICAR (p=0.001) on glucose uptake ( Figure 2B The initial statistical analysis that included all four pre-incubation conditions found that for 205 muscles incubated without insulin, there was a small, but significant main effect of serum on 206 total AMPK abundance (~15%, serum < no serum or AICAR; p<0.01; .
213
Post hoc analysis revealed pAMPK T172 with prior serum+AICAR > serum alone ( Figure 3A) . 214
For the secondary analysis excluding serum effects, there were no significant differences 215 among groups for total AMPK abundance (Table 1B) , but there was a significant main effect of 216 AICAR (p<0.001) on pAMPK
T172
. Post hoc analysis revealed pAMPK T172 with prior AICAR > no 217 insulin or AICAR (p<0.001) or with prior AICAR+insulin > insulin alone (p<0.001; Figure 3B ). 218
219
Akt 220
In the initial analysis for all four incubation conditions in muscles without insulin, there was a 221 small but significant effect of AICAR and an interaction effect on total Akt abundance (9-14%, no 222 AICAR > AICAR and serum < no serum; p<0.05; Table 1A ). In the initial analysis for muscles 223 incubated with insulin, there were no significant differences among groups in total Akt 224 abundance (Table 1A) Figure 4A ). In the secondary analysis excluding serum 232 and serum+AICAR, there was a significant main effect of insulin (p<0.001) on pAkt
T308
. Post hoc 233 analysis revealed pAkt T308 with insulin > no insulin (p<0.001) and AICAR+insulin>AICAR alone 234 (p<0.001; Figure 4B) . 235
There was a significant main effect of serum on pAkt S473 (p<0.05; Figure 5A ). Post hoc 236 analysis revealed pAkt S473 with serum > no AICAR or serum (p<0.05) and serum+AICAR > 237 AICAR alone (p<0.05; Figure 5A ). For muscles incubated with insulin, there was also a 238 significant main effect of serum on pAkt S473 (p<0.001; Figure 5A ). Post hoc analysis revealed 239 pAkt S473 with prior serum+AICAR > AICAR alone (p<0.05; Figure 5A ). In the secondary analysis 240 excluding serum and serum+AICAR, there was a significant main effect of insulin (p<0.001) on 241
. Post hoc analysis revealed pAkt S473 values with insulin > without AICAR or insulin 242 (p<0.001) and insulin+AICAR > AICAR alone (p<0.001; Figure 5B ). 243
244
AS160 245
For the initial statistical analysis on muscles incubated without insulin, there was a main 246 effect of serum on total AS160 abundance (~50% decrease with serum, serum < no serum; 247 p<0.001; Table 1A ). For muscles incubated with insulin, there was a main effect of serum on 248 total AS160 abundance (60-70%, serum < no serum; p<0.001; Figure 6A ). Secondary analysis for pAS160 S588 without serum or serum+AICAR used 256 the Kruskal-Wallis one-way ANOVA and Tukey post hoc tests because transformations failed 257 to normalize the data. This analysis indicated that insulin led to greater pAS160 S588 with insulin > 258 no AICAR or insulin (p<0.05) and AICAR+insulin>AICAR alone (p<0.05; Figure 6B ). 259
For muscles incubated without insulin, a significant main effect of serum (p<0.001) was 260 present on pAS160 Figure 7A ). Secondary analysis 266 using two-way ANOVA found there were significant main effects of insulin (p<0.001) and AICAR 267 on pAS160
T642
. Post hoc analysis revealed pAS160 T642 was increased by AICAR either in the 268 absence (p<0.05) or presence of insulin (p<0.05), and also increased by insulin either in the 269 absence (p<0.01) or presence of AICAR (p<0.01; Figure 7B ). 270
For muscles incubated without insulin, a main effect of AICAR was present on pAS160 S704 271 (p=0.01). Post hoc analysis revealed pAS160 S704 with prior serum > KHB (p<0.05), prior AICAR 272 > No AICAR or serum (p<0.01), and prior serum+AICAR > serum alone (p<0.05; Figure 8A ). 273
For muscles incubated with insulin, a main effect of AICAR on pAS160 S704 was present 274 (p<0.01). Post hoc analysis revealed pAS160 S704 with prior serum > the No AICAR or serum 275 D r a f t (p<0.05; Figure 8A ). Secondary analysis indicated a main effect of AICAR was present on 277 pAS160 S704 (p<0.001). Post hoc analysis revealed that pAS160 S704 with AICAR alone > No 278 insulin or AICAR (p<0.001) and with AICAR+insulin > AICAR alone (p<0.001; Figure 8B) . 279
In the initial statistical analysis for muscles treated without and with serum, there was no 282 main effect of serum or AICAR on GLUT4 ( Figure 9A ). In the secondary analysis, there was no 283 main effect of insulin or AICAR on GLUT4 ( Figure 9B ). There was no main effect of serum or 284 AICAR on hexokinase II (HKII) with insulin, but for muscles incubated without insulin, there was 285 a significant main effect of serum on HKII expression (p<0.01; Figure 10A ). Post hoc analysis 286 indicated HKII with serum < No AICAR or serum (p<0.05) and serum+AICAR < AICAR alone 287 (p<0.01; Figure 10A ). There was no main effect of insulin or AICAR on hexokinase II expression 288 ( Figure 10B) . 289
290
Discussion 291
The primary aim of the current study was to determine whether a single brief, prior exposure 292 to the AMPK activator AICAR would lead to subsequently increased glucose uptake in insulin-293 stimulated skeletal muscles from old rats. Accordingly, the most important finding in this study of 294 old rats was that prior AICAR treatment resulted in enhanced glucose uptake in muscles that 295 were subsequently stimulated with insulin compared to muscles without prior AICAR treatment. 296
Prior serum incubation was not essential for this effect, i.e., it was found with both the initial 297 statistical analysis that included the serum-treated muscles and the secondary statistical 298 analysis that eliminated the serum-treated conditions. Prior AICAR treatment led to greater 299 pAMPK T172 , pAS160 S704 and pAS160 T642 without altering pAkt
S473
, pAkt T308 or the abundance of 300 GLUT4 or HKII. In addition, prior serum+AICAR treatment, but not serum or AICAR alone, led to 301 D r a f t greater glucose uptake only in the absence of insulin. The effects of AICAR and/or serum on 302 glucose uptake were not attributable to increases in GLUT4 or HKII protein abundance. 303
The design for the current study examining male 24 month old rats was primarily based on 304 the protocol developed in the original study by Fisher et al. (2002) who evaluated young (120AICAR treatment increased insulin-stimulated glucose uptake by isolated muscles is consistent 307 with two earlier studies that evaluated isolated muscles from young animals (Fisher et al. 2002; 308 Kjobsted et al. 2015) . Similar to the current study, Fisher et al. (2002) reported that in young 309 rats, insulin-stimulated glucose uptake by isolated epitrochlearis muscles 3.5 h after incubation 310 with rat serum+AICAR exceeded values for muscles incubated in serum without AICAR or for 311 muscles that were incubated with AICAR alone. Kjøbsted et al. (2015) evaluated the effects of 312 prior AICAR and serum on subsequent glucose uptake by isolated muscles from female mice. 313
The mice were ~4 months of age when studied (Rasmus Kjøbsted, personal communication) . 314 Similar to the current study, they reported that glucose uptake by insulin-stimulated extensor 315 digitorum longus (EDL) muscles was greater in muscles after exposure to human serum+AICAR 316 versus muscles incubated with only serum (Kjobsted et al. 2015) . In one of their four 317 experiments, prior serum+AICAR compared to controls also resulted in a small, but significant 318 increase in EDL glucose uptake in the absence of insulin, and there was a non-significant trend 319
for an increase in their other three experiments (Kjobsted et al. 2015) . Although it is uncertain if 320 muscles from old female rats would respond similarly to the old male rats in the current study, 321 the results from Kjøbsted et al. (2015) indicate that the enhanced insulin-stimulated glucose 322 uptake after AICAR treatment can also occur in females (Kjobsted et al. 2015) . 323
There were several differences with regard to effects of serum and/or AICAR on glucose 324 uptake among the current study and the previous ones. The current study found that without 325 insulin, prior serum+AICAR led to subsequently enhanced glucose uptake in muscle from old 326 rats whereas Fisher et al. found glucose uptake was not different in muscles incubated withoutD r a f t insulin after serum+AICAR treatment versus no serum and AICAR (Fisher et al. 2002) . In the 328 current study, prior AICAR incubation without serum effectively increased insulin-stimulated 329 glucose uptake by epitrochlearis muscles from old rats, whereas Fisher et al. found that priorby Fisher et al. was identical with regard to species, sex, use of epitrochlearis muscle, 333 incubation durations, AICAR concentration, and glucose analog, but they differed with regard to 334 the age and strain of the rats and insulin concentration (200 versus 30 µU/ml) (Fisher et al. 335
2002). The current study and the study by Kjøbsted et al. differed with regard to species, sex, 336 muscles, source of serum (rat versus human), AICAR concentration (2 versus 1 mM), duration 337 of incubation after AICAR exposure (3.5 versus 6.5 h), feeding status of their animals (fasted 338 versus fed), and glucose analog (3-MG versus 2-deoxyglucose). In addition, they did not report 339 the independent effects of either serum or AICAR and did not test if serum was required for the 340 effect of prior AICAR treatment on insulin-stimulated glucose uptake by EDL muscles from 341 young mice (Kjobsted et al. 2015) . Thus, three studies have evaluated the effects of prior 342 AICAR treatment on insulin-stimulated glucose uptake by isolated rodent muscles and found 343 that prior AICAR consistently leads to a subsequent increase in insulin sensitivity in rat 344 epitrochlearis and mouse EDL. However, these studies have varied with regard to the effects of 345 prior serum and/or AICAR incubation on subsequent insulin-independent glucose uptake and 346 with regard to the serum being necessary for the effect of prior AICAR on insulin-stimulated 347 glucose uptake. The reasons for differing results among these studies are unclear, including 348 why prior AICAR treatment in the absence of serum resulted in greater glucose uptake in 349 insulin-stimulated muscles in the current study. It seems possible that the use of substantially 350 older animals in the current study may be particularly relevant for the different results compared 351 to the findings of the previous studies with much younger animals.
D r a f t
With or without serum, prior AICAR treatment resulted in greater pAMPK T172 in muscles that 353 were subsequently incubated either with or without insulin. These results correspond with the 354 observations by Kjøbsted et al. (Kjobsted et al. 2015) in isolated mouse EDL muscles several 355 hours after incubation with serum+AICAR. In the current study, the magnitude of the AICAR-356 induced increase in pAMPK T172 was similar for muscles incubated 1) with or without serum and 357
2) with or without insulin. However, insulin-independent glucose uptake was increased only for 358 the muscles after prior incubation with serum+AICAR. AS160 phosphorylation on both Thr642 359 and Ser588 has been linked to enhanced glucose uptake, and phosphorylation on both sites 360 was increased in the serum+AICAR muscles compared to muscles that were incubated in the 361 absence of either serum or AICAR. However, in the absence of insulin, prior incubation with 362 serum alone induced a similar increase in phosphorylation on both sites compared to 363 serum+AICAR without causing increased insulin-independent glucose uptake. In the presence 364 or absence of insulin, pAS160 S704 was also increased with prior serum+AICAR compared to 365 serum alone, but it was not greater than AICAR alone, which did not increase insulin-366 independent glucose uptake. Taken together, these results indicate that neither enhanced 367 AMPK nor AS160 phosphorylation is sufficient to explain the influence of prior serum+AICAR on 368 insulin-independent glucose uptake. 369
We also probed the effects of prior AICAR treatment on Akt and other phosphorylation sites 370 on AS160 to gain insights into the observed influence of AICAR on subsequent insulin-371 stimulated glucose uptake. Incubation of skeletal muscle with AICAR mimics several effects of 372 exercise, including both AMPK activation and a subsequent increase in insulin-stimulated 373 glucose uptake several hours after exercise cessation. It has been suggested that prior exercise 374 and prior AICAR treatment may share some of the same mechanisms to induce improved 375 insulin sensitivity (Kjobsted et al. 2015) . Substantial evidence indicates that increased insulin-376 stimulated glucose uptake after acute exercise is not secondary to enhanced insulin signaling at 377 proximal steps including activation of Akt (Funai et al. 2009; Funai et al. 2010; Schweitzer et al. D r a f t greater phosphorylation on Ser704, an AMPK phosphosite. Importantly, they reported that 384 effects of prior AICAR on pSer704, pThr642 and insulin-stimulated glucose uptake were 385 eliminated in muscles of mice with genetically induced AMPK deficiency. They also discovered 386 that mutating AS160 Ser704 to Ala704 prevented AS160 phosphorylation on this AMPK-387 phosphosite and resulted in substantially lower insulin-stimulated pThr642, strongly suggesting 388 that pSer704 favors greater pThr642 (Kjobsted et al. 2015) . Therefore, we evaluated the 389 influence of prior AICAR on AS160 phosphorylation. Analysis that excluded the serum-treated 390 conditions in the current study clearly demonstrated that prior AICAR-treatment increased 391 AS160 phosphorylation on both Ser704 and Thr642, either in the absence or presence of 392 insulin. When the serum-treated conditions were also included in the statistical analysis, AS160 393 phosphorylation on all three sites was increased by AICAR-treatment in the insulin-stimulated 394 muscles, and prior AICAR also induced elevated pSer588 and pS704 in muscles incubated 395 without insulin. In the insulin-stimulated muscles, there was an effect of prior serum-treatment 396 on Akt phosphorylation on both Ser473 and Thr308, but there was no effect of AICAR on Akt 397 phosphorylation on either site. These results in response to prior AICAR-treatment are similar to 398 the previously reported observation that prior acute exercise does not amplify proximal insulin 399 signaling steps (Castorena et al. 2014) . 400 TBC1D1 is an AS160 analog that can be phosphorylated on Ser231 by AMPK and on 401
Thr590 by Akt (Cartee 2015b). However, greater TBC1D1 phosphorylation on these sites does 402 not appear to be sufficient for greater insulin-stimulated glucose uptake after prior AICAR 403 treatment (Kjobsted et al. 2015) . Furthermore, either prior exercise or prior electricallyD r a f t stimulated muscle contraction leading to subsequently increased insulin-stimulated glucose 405 uptake does not lead to a subsequent increase in TBC1D1 phosphorylation on these sites 406 (Pehmoller et al. 2012; Kjobsted et al. 2015) . 407
Although AICAR has long been known to enter cells and activate AMPK (Corton et al. 408 1995) , AICAR also has biological actions that occur separate from AMPK activation (Rao et al. 409 2016) . However, the effects of prior AICAR treatment on glucose uptake in insulin-stimulated 410 skeletal muscle observed in the current study seem likely to be AMPK-dependent given that 411 AICAR effects on insulin-mediated glucose uptake were reported to be abolished in multiple 412 genetic mouse models with deficient AMPK activity (Kjobsted et al. 2015) . 413
Sustained or repeated intermittent AMPK activation by AICAR can lead to increased GLUT4 414 expression in skeletal muscle of young rats (Holloszy 2011). Qiang et al. (2007) reported that 415 daily injections of AICAR for one week could also increase GLUT4 protein abundance and both 416 basal and insulin-stimulated glucose uptake in skeletal muscle of 24 month-old rats. Neither Akt 417 nor AS160 phosphorylation were reported in this earlier study (Qiang et al. 2007 ). In contrast, 418 none of the observed increases in glucose uptake in the current study were attributable to 419 greater GLUT4 protein abundance. These results suggest that the effects of acute prior serum 420 and/or AICAR on glucose uptake, both with and without insulin, were likely related to differences 421 in GLUT4 translocation. Although there is evidence that AMPK activation by AICAR can induce 422 increased HKII expression in skeletal muscle (Ojuka et al. 2000; Stoppani et al. 2002) , prior 423 AICAR treatment did not alter HKII protein abundance in this study, and HKII would not 424 influence the uptake of the non-metabolizable glucose analog used to assess glucose uptake in 425 these experiments. 426
In conclusion, previous research has demonstrated that older rats are able to increase 427 insulin-stimulated glucose uptake by skeletal muscle after acute exercise (Cartee et al. 1993; 428 Xiao et al. 2013) . However, because some older individuals may have an impaired capacity to 429 perform exercise, it would be useful to identify alternative approaches to induce some of theD r a f t important health-related benefits of exercise, including increased insulin sensitivity. The current 431 study offers novel evidence that a brief prior exposure to AICAR, a pharmacological activator of 432 AMPK, can increase glucose uptake in insulin-stimulated isolated skeletal muscles from old 433 rats. The results also provide insights into potential mechanisms for this outcome. Our working 434 hypothesis is that the mechanism in the muscles from older rats involves the AMPK-AS160 435 signaling axis that was identified by Kjøbsted et al. (2015) in their study of the effects of prior 436 AICAR on insulin-stimulated glucose uptake in isolated mouse skeletal muscle (Kjobsted et al. 437 2015) . 
